Frank Follmann is the Director of Infectious Disease Immunology and Head of Chlamydia Vaccine Research at Statens Serum Institut. He is a Civil Engineer (Chemistry) by training and later acquired a PhD in Medicine from the University of Copenhagen. In 2012, he completed an executive educational program for future leaders in research and technology industries from Harvard Business School. From 2007 and onward, he has been leading a multidisciplinary team with the goal to develop a Chlamydia vaccine, a vaccine that in 2016 entered clinical trial testing. He is responsible for pre-clinical antigen discovery, vaccine design and formulation. Since March 2016, he is also the Director of Dept. of Infectious Disease Immunology at Statens Serum Institut. 2017-present: Scientific project manager for H2020 project TracVac, developing a Trachoma vaccine (https://www.trachoma-vaccine.org/).